VERWENDUNG VON 5-HT4 ANTAGONISTEN ZUR ÜBERWINDUNG DER GASTROINTESTINALEN BESCHÄDIGUNG, DIE DURCH INHIBITOREN DER SEROTONIN-WIEDERAUFNAHME HERVORGERUFEN WERDEN

VERWENDUNG VON 5-HT4 ANTAGONISTEN ZUR ÜBERWINDUNG DER GASTROINTESTINALEN BESCHÄDIGUNG, DIE DURCH INHIBITOREN DER SEROTONIN-WIEDERAUFNAHME HERVORGERUFEN WERDEN

PCT No. PCT/EP97/00586 Sec. 371 Date Aug. 11, 1998 Sec. 102(e) Date Aug. 11, 1998 PCT Filed Feb. 7, 1997 PCT Pub. No. WO97/29739 PCT Pub. Date Aug. 21, 1997The present invention concerns the use of receptor antagonists of the 5HT4 receptor for avoiding, alleviating, suppressing or overcoming the gas...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: MEULEMANS, ANN, LOUISE, GABRIELLE, 30, BOSMANS, JEAN-PAUL, RENE, MARIE, ANDRE
Format: Patent
Sprache:ger
Schlagworte:
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator MEULEMANS, ANN, LOUISE, GABRIELLE
30
BOSMANS, JEAN-PAUL, RENE, MARIE, ANDRE
description PCT No. PCT/EP97/00586 Sec. 371 Date Aug. 11, 1998 Sec. 102(e) Date Aug. 11, 1998 PCT Filed Feb. 7, 1997 PCT Pub. No. WO97/29739 PCT Pub. Date Aug. 21, 1997The present invention concerns the use of receptor antagonists of the 5HT4 receptor for avoiding, alleviating, suppressing or overcoming the gastrointestinal side-effects of serotonin reuptake inhibitors. The present invention also concerns pharmaceutical formulations comprising 5HT4-receptor antagonists for alleviating, suppressing or overcoming the gastrointestinal side-effects of serotonin reuptake inhibitors, as well as pharmaceutical compositions comprising 5HT4 receptor antagonists and serotonin reuptake inhibitors.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_ATE250931TT1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>ATE250931TT1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_ATE250931TT13</originalsourceid><addsrcrecordid>eNqNzE1qAkEQBeDZuAjRO5R7B_yJC5c90zXdBbEaqqtnwI1I6KyCCnoEj-Eid_Fi6ZAcwNWDx_feS_XdowzINrGDPjCsa69vYFiNC0xRkWGXBB73pjj6cxYFnIkqgVgxKrF5L67B2PrHzZIraAaWEGyS1gOxp4Y0SEG_24gStLxzPRCWwqSOjd8ieJQ-iENJXaEDikUeV6PPw9clT_7ztZp2qK2v8_m0z5fz4SMf83VvFJfr-Wa1UF2snjE_HWBHwg</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>VERWENDUNG VON 5-HT4 ANTAGONISTEN ZUR ÜBERWINDUNG DER GASTROINTESTINALEN BESCHÄDIGUNG, DIE DURCH INHIBITOREN DER SEROTONIN-WIEDERAUFNAHME HERVORGERUFEN WERDEN</title><source>esp@cenet</source><creator>MEULEMANS, ANN, LOUISE, GABRIELLE ; 30 ; BOSMANS, JEAN-PAUL, RENE, MARIE, ANDRE</creator><creatorcontrib>MEULEMANS, ANN, LOUISE, GABRIELLE ; 30 ; BOSMANS, JEAN-PAUL, RENE, MARIE, ANDRE</creatorcontrib><description>PCT No. PCT/EP97/00586 Sec. 371 Date Aug. 11, 1998 Sec. 102(e) Date Aug. 11, 1998 PCT Filed Feb. 7, 1997 PCT Pub. No. WO97/29739 PCT Pub. Date Aug. 21, 1997The present invention concerns the use of receptor antagonists of the 5HT4 receptor for avoiding, alleviating, suppressing or overcoming the gastrointestinal side-effects of serotonin reuptake inhibitors. The present invention also concerns pharmaceutical formulations comprising 5HT4-receptor antagonists for alleviating, suppressing or overcoming the gastrointestinal side-effects of serotonin reuptake inhibitors, as well as pharmaceutical compositions comprising 5HT4 receptor antagonists and serotonin reuptake inhibitors.</description><edition>7</edition><language>ger</language><subject>HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2003</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20031015&amp;DB=EPODOC&amp;CC=AT&amp;NR=E250931T1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20031015&amp;DB=EPODOC&amp;CC=AT&amp;NR=E250931T1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>MEULEMANS, ANN, LOUISE, GABRIELLE</creatorcontrib><creatorcontrib>30</creatorcontrib><creatorcontrib>BOSMANS, JEAN-PAUL, RENE, MARIE, ANDRE</creatorcontrib><title>VERWENDUNG VON 5-HT4 ANTAGONISTEN ZUR ÜBERWINDUNG DER GASTROINTESTINALEN BESCHÄDIGUNG, DIE DURCH INHIBITOREN DER SEROTONIN-WIEDERAUFNAHME HERVORGERUFEN WERDEN</title><description>PCT No. PCT/EP97/00586 Sec. 371 Date Aug. 11, 1998 Sec. 102(e) Date Aug. 11, 1998 PCT Filed Feb. 7, 1997 PCT Pub. No. WO97/29739 PCT Pub. Date Aug. 21, 1997The present invention concerns the use of receptor antagonists of the 5HT4 receptor for avoiding, alleviating, suppressing or overcoming the gastrointestinal side-effects of serotonin reuptake inhibitors. The present invention also concerns pharmaceutical formulations comprising 5HT4-receptor antagonists for alleviating, suppressing or overcoming the gastrointestinal side-effects of serotonin reuptake inhibitors, as well as pharmaceutical compositions comprising 5HT4 receptor antagonists and serotonin reuptake inhibitors.</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2003</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNzE1qAkEQBeDZuAjRO5R7B_yJC5c90zXdBbEaqqtnwI1I6KyCCnoEj-Eid_Fi6ZAcwNWDx_feS_XdowzINrGDPjCsa69vYFiNC0xRkWGXBB73pjj6cxYFnIkqgVgxKrF5L67B2PrHzZIraAaWEGyS1gOxp4Y0SEG_24gStLxzPRCWwqSOjd8ieJQ-iENJXaEDikUeV6PPw9clT_7ztZp2qK2v8_m0z5fz4SMf83VvFJfr-Wa1UF2snjE_HWBHwg</recordid><startdate>20031015</startdate><enddate>20031015</enddate><creator>MEULEMANS, ANN, LOUISE, GABRIELLE</creator><creator>30</creator><creator>BOSMANS, JEAN-PAUL, RENE, MARIE, ANDRE</creator><scope>EVB</scope></search><sort><creationdate>20031015</creationdate><title>VERWENDUNG VON 5-HT4 ANTAGONISTEN ZUR ÜBERWINDUNG DER GASTROINTESTINALEN BESCHÄDIGUNG, DIE DURCH INHIBITOREN DER SEROTONIN-WIEDERAUFNAHME HERVORGERUFEN WERDEN</title><author>MEULEMANS, ANN, LOUISE, GABRIELLE ; 30 ; BOSMANS, JEAN-PAUL, RENE, MARIE, ANDRE</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_ATE250931TT13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>ger</language><creationdate>2003</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>MEULEMANS, ANN, LOUISE, GABRIELLE</creatorcontrib><creatorcontrib>30</creatorcontrib><creatorcontrib>BOSMANS, JEAN-PAUL, RENE, MARIE, ANDRE</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>MEULEMANS, ANN, LOUISE, GABRIELLE</au><au>30</au><au>BOSMANS, JEAN-PAUL, RENE, MARIE, ANDRE</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>VERWENDUNG VON 5-HT4 ANTAGONISTEN ZUR ÜBERWINDUNG DER GASTROINTESTINALEN BESCHÄDIGUNG, DIE DURCH INHIBITOREN DER SEROTONIN-WIEDERAUFNAHME HERVORGERUFEN WERDEN</title><date>2003-10-15</date><risdate>2003</risdate><abstract>PCT No. PCT/EP97/00586 Sec. 371 Date Aug. 11, 1998 Sec. 102(e) Date Aug. 11, 1998 PCT Filed Feb. 7, 1997 PCT Pub. No. WO97/29739 PCT Pub. Date Aug. 21, 1997The present invention concerns the use of receptor antagonists of the 5HT4 receptor for avoiding, alleviating, suppressing or overcoming the gastrointestinal side-effects of serotonin reuptake inhibitors. The present invention also concerns pharmaceutical formulations comprising 5HT4-receptor antagonists for alleviating, suppressing or overcoming the gastrointestinal side-effects of serotonin reuptake inhibitors, as well as pharmaceutical compositions comprising 5HT4 receptor antagonists and serotonin reuptake inhibitors.</abstract><edition>7</edition><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language ger
recordid cdi_epo_espacenet_ATE250931TT1
source esp@cenet
subjects HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
title VERWENDUNG VON 5-HT4 ANTAGONISTEN ZUR ÜBERWINDUNG DER GASTROINTESTINALEN BESCHÄDIGUNG, DIE DURCH INHIBITOREN DER SEROTONIN-WIEDERAUFNAHME HERVORGERUFEN WERDEN
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-04T02%3A04%3A35IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=MEULEMANS,%20ANN,%20LOUISE,%20GABRIELLE&rft.date=2003-10-15&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EATE250931TT1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true